-
HC Wainwright Reaffirms Buy Rating for Arrowhead Pharmaceuticals (NASDAQ:ARWR)
Source: Buzz FX / 20 Dec 2024 10:36:12 America/Chicago
HC Wainwright Reaffirms Buy Rating for Arrowhead Pharmaceuticals (NASDAQ:ARWR) Written by MarketBeat December 20, 2024 Share Link copied to clipboard. Arrowhead Pharmaceuticals ( NASDAQ:ARWR - Get Free Report ) 's stock had its "buy" rating
Read more...